Randy Lieberman is a Cardiology physician affiliated with Wayne State University. OpenAlex indexes 64 publications with 1,924 citations (h-index 13); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
4201 Saint Antoine St Ste 7b
Detroit, MI 482012153
Telephone
313-745-0233Provider last certified this registry record 25 Feb 2022.
Clinical trials
- Acute Carotid Sinus Endovascular Stimulation II Study
Sponsor: Medtronic Cardiac Rhythm and Heart Failure
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
30 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Novo Nordisk IncProgram year202515 payments$24,957openpaymentsdata.cms.gov ↗
- Medtronic, Inc.Program year202519 payments
- Amgen Inc.Program year202516 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
69.2%Beta blocker15.3%Metoprolol Succinate48%Carvedilol36%Metoprolol Tartrate16%Part D<11 patientsAngiotensin receptor-neprilysin inhibitor (ARNI)11.5%Entresto100%Part D≥36 patients+ 10 more classes in this area
Metabolism & gastrointestinal
15.5%SGLT2 inhibitor12.1%Jardiance85%Farxiga15%Part D<11 patientsGLP-1 receptor agonist2.1%Ozempic100%Part D<11 patients+ 1 more class in this area
Blood & clotting
15.3%Factor Xa inhibitor13.4%Eliquis52%Xarelto48%Part D≥23 patientsP2Y12 inhibitor1.9%Clopidogrel100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- EXHAUSTION OF THE REPOLARIZATION RESERVE AND QT INTERVAL DYNAMICS IN A COMPLEX CASE, IMPLICATIONS FOR QT INTERVAL PROLONGATION AND MANAGEMENT
Journal of the American College of Cardiology
2024 - Giant left main stem aneurysm in a patient with non‐sustained ventricular tachycardia: A case report
Clinical Case Reports
2024 - DMT310, a novel once-weekly topical treatment for patients with moderate-to-severe acne vulgaris: Results of a phase 2b randomized, double-blind, placebo-controlled trial
Journal of the American Academy of Dermatology
2023 - POSITIONAL ATRIAL TACHYCARDIA IN THE SETTING OF METASTATIC MALIGNANCY
Journal of the American College of Cardiology
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Sonia Hassan, MD
Wayne State University
Tinnakorn Chaiworapongsa, MD
Wayne State University
Robert Sokol, MD
Wayne State University
Robert Lisak, MD
Wayne State University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”